BlackRock Institutional Trust’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
Other funds holding SPPI
BFA
BlackRock Institutional Trust's SPPI Position: Q4 2016 in Review
BlackRock Institutional Trust increased its Spectrum Pharmaceuticals Inc (SPPI) stake by 3.3% in Q4 2016, buying an estimated $289K and bringing the position to 2,139,488 shares worth $9.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2433.
BlackRock Institutional Trust first reported a position in SPPI in Q2 2013 and has held it in 15 quarters since. The position peaked at $16M in Q3 2014. 139 funds tracked by Wall St. Rank hold SPPI as of Q4 2016.
- BlackRock Institutional Trust held 2,139,488 shares of Spectrum Pharmaceuticals Inc worth $9.48M as of Q4 2016.
- BlackRock Institutional Trust bought 68,982 Spectrum Pharmaceuticals Inc shares in Q4 2016, an estimated $289K.
- Spectrum Pharmaceuticals Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2433 holding.
- BlackRock Institutional Trust first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's Spectrum Pharmaceuticals Inc position peaked at $16M in Q3 2014.
- 139 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.